Biomerica, Inc.
BMRA
$0.5725
-$0.0315-5.22%
| 11/30/2024 | 08/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -9.46% | 61.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.46% | 61.92% | |||
| Cost of Revenue | -21.01% | 38.50% | |||
| Gross Profit | 51.21% | 1,345.00% | |||
| SG&A Expenses | -13.75% | 6.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.20% | 20.08% | |||
| Operating Income | 27.41% | 10.47% | |||
| Income Before Tax | 27.36% | 7.21% | |||
| Income Tax Expenses | -175.00% | -42.86% | |||
| Earnings from Continuing Operations | 27.81% | 7.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.81% | 7.39% | |||
| EBIT | 27.41% | 10.47% | |||
| EBITDA | 27.91% | 10.56% | |||
| EPS Basic | 29.03% | 7.46% | |||
| Normalized Basic EPS | 28.54% | 7.24% | |||
| EPS Diluted | 25.00% | 11.11% | |||
| Normalized Diluted EPS | 28.54% | 7.24% | |||
| Average Basic Shares Outstanding | 1.78% | 0.00% | |||
| Average Diluted Shares Outstanding | 1.78% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
